Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibandronate vs Zoledronic Acid After Denosumab Discontinuation
NCT07406685Phase 4Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2026
- Primary completion
- Aug 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ibandronate in osteoporosis, sponsored by National Taiwan University Hospital. Started Aug 2026; status: recruiting.
02
Drugs
ibandronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT07406685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07406685.